fbpx

Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

Johnson & Johnson to test experimental HIV vaccine in U.S., Europe

(Reuters) – Johnson & Johnson said on Friday it plans to conduct a late-stage study of its investigational vaccine for Human Immunodeficiency Virus (HIV) in several countries across the Americas and Europe, including the United States.

The drugmaker already has a mid-stage HIV vaccine study underway in five southern African countries.

There are currently no vaccines for HIV, a virus that weakens the body’s immune system.

JULY 12, 2019

https://www.reuters.com/

Share this:
July 15, 2019 / Pharma News